Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis-Reference-Cited by-同舟云学术

Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis

Published:2009-01 Issue:1 Volume:256 Page:89-103
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Merrill Jean E.,Hanak Susan,Pu Su-Fen,Liang Jinjun,Dang Chelsea,Iglesias-Bregna Deborah,Harvey Brian,Zhu Bin,McMonagle-Strucko Kathleen

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

http://link.springer.com/content/pdf/10.1007/s00415-009-0075-3.pdf

Reference51 articles.

1. Bjartmar C, Wujek JR, Trapp BD (2003) Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 206:165–171

2. Bechtold DA, Miller SJ, Dawson AC, Sun Y, Kapoor R, Berry D, Smith KJ (2006) Axonal protection in a model of multiple sclerosis using lamotrigine. J Neurol 253:1542–1551

3. Bruck W (2005) The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. J Neurol 252(Suppl 5): v/3–v/9

4. Bruneau J-M, Yea CM, Spinella-Jaegle S, Fudali C, Woodward K, Robson PA, Sautes C, Westwood R, Kuo EA, Williamson RA, Ruuth R (1998) Purification of human dihydro-orotate dehydrogenase and its inhibition by A77 1726, the active metabolite of leflunomide. Biochem J 336:299–303

5. Chalk JB, McCombe PA, Pender MP (2003) Conduction abnormalities are restricted to the central nervous system in experimental autoimmune encephalomyelitis induced by inoculation with proteolipid protein but not with myelin basic protein. Brain 117:975–986

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinically approved immunomodulators ameliorate behavioral changes in a mouse model of hereditary spastic paraplegia type 11;Frontiers in Neuroscience;2024-02-16

2. Polysialic acid promotes remyelination in cerebellar slice cultures by Siglec-E-dependent modulation of microglia polarization;Frontiers in Cellular Neuroscience;2023-07-10

3. Repurposing MS immunotherapies for CIDP and other autoimmune neuropathies: unfulfilled promise or efficient strategy?;Therapeutic Advances in Neurological Disorders;2023-01

4. Using an animal model to predict the effective human dose for oral multiple sclerosis drugs;Clinical and Translational Science;2022-11-23

5. Discovery of potential natural dihydroorotate dehydrogenase inhibitors and their synergism with brequinar via integrated molecular docking, dynamic simulations and in vitro approach;Scientific Reports;2022-11-09